BridgeMD
New treatment option for Socket Preservation
Official title The Local Effect of Vitamin K2 on Bone Remodeling in Socket Preservation
ClinicalTrials.gov ID: NCT06707909
What this study is testing
What is Menaquinone?
Menaquinone is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for socket preservation.
Also referred to as vitamin k2 (Menaquinone).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is a randomized controlled trial comparing the effects of socket grafting with crushed vitamin K2 (menaquinone)capsules versus no grafting on bone density and socket dimensions following tooth extraction. Patients are randomly assigned to one of two groups: Study Group (Group I): Patients receive socket grafting with crushed vitamin K2 (menaquinone) capsules.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80. Healthy volunteers may be eligible.
You may be able to join if
- Age \> 18 years without other age or gender restrictions.
- Patients requiring extraction of mandibular single-rooted teeth.
You likely can't join if
- Patients with systemic conditions affecting bone metabolism.
- Allergies or sensitivities to hydroxyapatite or Vitamin K2
- Untreated or residual periodontal disease;
- Uncontrolled diabetes (HbA1c \> 7.5%);
- Head and/or neck radiotherapy
- Immunosuppressive therapy
See the full eligibility criteria
- Age \> 18 years without other age or gender restrictions.
- Patients requiring extraction of mandibular single-rooted teeth.
- Patients with systemic conditions affecting bone metabolism.
- Allergies or sensitivities to hydroxyapatite or Vitamin K2
- Untreated or residual periodontal disease;
- Uncontrolled diabetes (HbA1c \> 7.5%);
- Head and/or neck radiotherapy
- Immunosuppressive therapy
- Pregnant or nursing
- Substance abuse
- Treated or under treatment with intravenous amino-bisphosphonates
- Patients participating in other studies, if the present protocol could not be properly followed.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Cairo Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Cairo Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.